Date: May 21, 2026 Source: Anglia Ruskin University Summary: A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term
GLP-1RA also reduced the risk of cardiovascular death by 13% (P = 0.016), nonfatal stroke by 16% (P = 0.007), hospitalization for heart failure by 10% (P = 0.023), all-cause mortality by 12% (P = 0.012), and the broad composite kidney outcome by 17% (P = 0.012), which was driven by a reduction in macroalbuminuria only (HR = 0.74, 0.670.82, P 18 years old) patients with T2DM
Wendland BE, Aghdassi E, Tam C, et al
A compliant product page should describe support for cellular energy metabolism and antioxidant balance
Infiltrating immune cells either exhibit anticancer responses or create an immunosuppressive environment (105)
It is helpful for gut health, too